| ISIN | LU3172323571 |
|---|---|
| Valor Number | |
| Bloomberg Global ID | |
| Fund Name | Swiss Life Funds (LUX) Equity Europe High Dividend EUR F Dis |
| Fund Provider |
Swiss Life Asset Management AG
Zürich, Switzerland Phone: +41 44 284 77 09 E-Mail: info@swisslife-am.com Web: www.swisslife-am.com |
| Fund Provider | Swiss Life Asset Management AG |
| Representative in Switzerland |
Swiss Life Asset Management AG Zürich Phone: +41 43 284 33 11 |
| Distributor(s) |
Swiss Life Asset Management AG Zürich Phone: +41 43 284 33 11 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Distribution |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The objective of this Sub-Fund is to achieve a high long term capital growth by investing in and/or being exposed to a diversified equity portfolio of European companies with, but not limited to above-average yearly dividend payments through direct or indirect investments via other UCITS and/or UCIs. |
| Peculiarities |
| Current Price * | 107.11 EUR | 16.01.2026 |
|---|---|---|
| Previous Price * | 107.18 EUR | 15.01.2026 |
| 52 Week High * | 107.18 EUR | 15.01.2026 |
| 52 Week Low * | 99.72 EUR | 17.10.2025 |
| NAV * | 107.11 EUR | 16.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 116,865,031 | |
| Unit/Share Assets *** | 10,555 | |
| Trading Information SIX | ||
| YTD Performance | +1.48% |
31.12.2025 - 16.01.2026
31.12.2025 16.01.2026 |
|---|---|---|
| YTD Performance (in CHF) | +1.43% |
31.12.2025 - 16.01.2026
31.12.2025 16.01.2026 |
| 1 month | +3.35% |
16.12.2025 - 16.01.2026
16.12.2025 16.01.2026 |
| 3 months | +6.93% |
16.10.2025 - 16.01.2026
16.10.2025 16.01.2026 |
| 6 months | +7.11% |
15.10.2025 - 16.01.2026
15.10.2025 16.01.2026 |
| 1 year | - | - |
| 2 years | - | - |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 6.25% | |
|---|---|---|
| British American Tobacco PLC | 6.01% | |
| Roche Holding AG | 3.92% | |
| TotalEnergies SE | 3.68% | |
| Allianz SE | 3.66% | |
| Deutsche Post AG | 3.59% | |
| Zurich Insurance Group AG | 3.46% | |
| Shell PLC | 3.36% | |
| Sanofi SA | 3.05% | |
| Imperial Brands PLC | 2.69% | |
| Last data update | 31.12.2025 | |
| TER | |
|---|---|
| TER date | |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |